A new nanodrug for endometriosis pain and lesions
Development of anti-inflammatory nanodrug for endometriosis treatment
['FUNDING_R01'] · MICHIGAN STATE UNIVERSITY · NIH-11141616
This project explores a new non-hormonal nanodrug to reduce inflammation and lesions in women with endometriosis.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MICHIGAN STATE UNIVERSITY (nih funded) |
| Locations | 1 site (EAST LANSING, UNITED STATES) |
| Trial ID | NIH-11141616 on ClinicalTrials.gov |
What this research studies
Endometriosis affects many women, causing chronic pain and infertility, and current treatments often have side effects or don't prevent recurrence. This research focuses on a new approach using tiny particles called nanoceria, which act as powerful anti-inflammatory agents. These nanoparticles are designed to specifically target and accumulate in endometriosis lesions, helping to reduce inflammation and shrink the lesions. Early findings in animal models suggest this nanodrug can significantly lessen the number of endometriosis lesions.
Who could benefit from this research
Good fit: This research is relevant for women experiencing endometriosis, especially those with chronic pelvic pain and infertility who are seeking new treatment options.
Not a fit: Patients without endometriosis or those whose condition is well-managed by existing treatments may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this nanodrug could offer a new, non-hormonal treatment option for endometriosis that specifically targets lesions and reduces pain with fewer side effects.
How similar studies have performed: Preliminary results in mouse models have shown that this specific nanodrug can reduce endometriotic lesions, indicating a promising new direction.
Where this research is happening
EAST LANSING, UNITED STATES
- MICHIGAN STATE UNIVERSITY — EAST LANSING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KIM, TAEHO — MICHIGAN STATE UNIVERSITY
- Study coordinator: KIM, TAEHO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.